Paper Details

  1. Home
  2. Paper Details

Risperidone versus typical antipsychotic medication for schizophrenia.

Author: ClarkeA, GilbodyS, HunterR, KennedyE, SongF

Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.

Overview

"Conventional" antipsychotics like haloperidol and chlorpromazine are commonly used for schizophrenia, but 5-25% of patients respond poorly. Side effects also lead to compliance issues. While these drugs are effective for "positive" symptoms, there is little evidence they improve "negative" symptoms. Risperidone, a "new generation" antipsychotic, is believed to cause fewer movement disorders and potentially improve negative symptoms.
Paper Details　
Original Abstract of the Article :
The 'conventional' neuroleptic drugs, such as haloperidol and chlorpromazine, are frequently used as the first line treatment for people with schizophrenia. However, about 5-25% of these people show poor response to these treatments and side effects often makes compliance with the 'older generation'...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/14651858.CD000440

データ提供：米国国立医学図書館（NLM）

Risperidone: A New Hope for Schizophrenia Treatment

This research explores the use of risperidone, a newer generation antipsychotic medication, for the treatment of schizophrenia. The study examines the efficacy and safety of risperidone in comparison to traditional antipsychotics, such as haloperidol and chlorpromazine, which are often used as first-line treatment. The researchers point out that while traditional antipsychotics are effective in managing positive symptoms of schizophrenia, they often lead to side effects and may not adequately address negative symptoms. Risperidone, on the other hand, has been shown to be effective in treating both positive and negative symptoms, with a potentially lower risk of movement disorders.

A Light in the Desert: Finding Effective Treatment for Schizophrenia

The research suggests that risperidone could be a more effective and well-tolerated treatment option for schizophrenia compared to traditional antipsychotics. This study highlights the importance of continued research and the development of newer and more effective antipsychotic medications that can effectively manage both positive and negative symptoms, ultimately improving the lives of patients with schizophrenia.

The Shifting Sands of Schizophrenia Treatment

The landscape of schizophrenia treatment is constantly changing, with new research and advances leading to a better understanding of the disease and more effective treatments. This study offers a glimpse into the potential benefits of risperidone, emphasizing the need for ongoing research to develop even more effective and well-tolerated therapies for this complex and challenging disorder.

Dr.Camel's Conclusion

This research explores the potential benefits of risperidone as a treatment option for schizophrenia, highlighting its potential to address both positive and negative symptoms while minimizing side effects. The study underscores the importance of continued research and development in the field of antipsychotic medications to improve the lives of patients with schizophrenia and provide them with the most effective and well-tolerated treatments available.
Date :
  1. Date Completed 2000-07-06
  2. Date Revised 2022-03-21
Further Info :

Pubmed ID

10796543

DOI: Digital Object Identifier

10.1002/14651858.CD000440

Related Literature

Article Analysis
・Effective treatment of schizophrenia
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.